US equities
|
SPCX
$168.41
▲+5.94%
NVDA
$237.34
▲+1.45%
MU
$1,066.48
▼-0.78%
TSLA
$378.70
▲+2.19%
MSFT
$525.57
▲+1.55%
SNDK
$1,715.30
▼-0.27%
INTC
$117.27
▼-1.73%
META
$743.55
▲+2.12%
SPCX
$168.41
▲+5.94%
NVDA
$237.34
▲+1.45%
MU
$1,066.48
▼-0.78%
TSLA
$378.70
▲+2.19%
MSFT
$525.57
▲+1.55%
SNDK
$1,715.30
▼-0.27%
INTC
$117.27
▼-1.73%
META
$743.55
▲+2.12%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Karuna Therapeutics, Inc. - Common Stock
(NQ:
KRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Karuna Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Karuna Therapeutics to Present at Upcoming Investor Conferences
May 04, 2021
From
Karuna Therapeutics, Inc.
Via
Business Wire
10 Biggest Price Target Changes For Monday
↗
April 26, 2021
Credit Suisse boosted Facebook, Inc. (NASDAQ: FB) price target from $330 to $371. Facebook shares rose 0.4% to $302.18 in pre-market trading. Citigroup raised the price target...
Via
Benzinga
Cramer Gives His Opinion On Regeneron, Bumble And More
↗
April 14, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said NIH and CDC should get their act together and start pushing what Regeneron Pharmaceuticals Inc (NASDAQ: REGN)...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >